0000898432-21-000772.txt : 20211209 0000898432-21-000772.hdr.sgml : 20211209 20211209214027 ACCESSION NUMBER: 0000898432-21-000772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211207 FILED AS OF DATE: 20211209 DATE AS OF CHANGE: 20211209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAWKINS JAMES B CENTRAL INDEX KEY: 0000898243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 211483504 MAIL ADDRESS: STREET 1: C/O IRADIMED CORPORATION STREET 2: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 4 1 form4.xml X0306 4 2021-12-07 0001325618 IRADIMED CORP IRMD 0000898243 HAWKINS JAMES B C/O IRADIMED CORPORATION 1025 WILLA SPRINGS DR. WINTER SPRINGS FL 32708 true Common Stock 2021-12-07 4 A 0 18743 1.48 A 36011 D Common Stock 2021-12-07 4 S 0 18743 47.073 D 17268 D Common Stock 2021-12-07 4 M 0 4222 A 21490 D Common Stock 2021-12-08 4 A 0 559 1.48 A 22049 D Common Stock 2021-12-08 4 S 0 559 48.5 D 21490 D Stock Options (Right to Buy) 1.48 2021-12-07 4 M 0 18743 0 D 2023-12-31 Common Stock 18743 10000 D Restricted Stock Units 2021-12-07 4 M 0 4222 0 D Common Stock 4222 2037 D Restricted Stock Units 2021-12-07 4 A 0 2071 0 A Common Stock 2071 2071 D Stock Options (Right to Buy) 1.48 2021-12-08 4 M 0 559 0 D 2023-12-31 Common Stock 559 9441 D This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. This transaction was executed in multiple trades at prices ranging from $46.30 to $48.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Restricted Stock Units convert to common stock on a one-for-one basis. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. /s/ James Hawkins 2021-12-09